Cochlear hair cell loss in single-dose versus continuous round window administration of gentamicin

Acta Oto-Laryngologica

Volumn 125, Issue 4, 2005, Pages 340-345

  Wagner, Niels ^a   Cayé Thomasen, Per ^a   Laurell, Göran ^b   Bagger Sjöbäck, Dan ^b   Thomsen, Jens ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Inner ear morphology; M ni re's disease; Ototoxicity

Indexed keywords

ANORFIN; BUPRENORPHINE; GENTAMICIN; KETOPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; PHALLOIDIN; ROMEFEN VET; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASILAR MEMBRANE; CATHETER; CELL LABELING; CELL LOSS; COCHLEA; COCHLEA FENESTRA; CONTINUOUS INFUSION; CONTROLLED STUDY; CORTI ORGAN; DOSE RESPONSE; DRUG EFFECT; DRUG INFUSION; GUINEA PIG; HAIR CELL; INNER EAR; LOW DRUG DOSE; MALE; MENIERE DISEASE; MIDDLE EAR; MYRINGOTOMY; NONHUMAN; OSMOTIC PUMP; OTOTOXICITY; PRIORITY JOURNAL; SINGLE DRUG DOSE;

ADMINISTRATION, TOPICAL; ANIMALS; ANTI-BACTERIAL AGENTS; BASILAR MEMBRANE; CELL COUNT; COCHLEA; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; GENTAMICINS; GUINEA PIGS; HAIR CELLS; INFUSION PUMPS, IMPLANTABLE; MALE; ORGAN OF CORTI; ROUND WINDOW;

EID: 17144425391     PISSN: 00016489     EISSN: None     Source Type: Journal    
DOI: 10.1080/00016480510026881     Document Type: Article

References (23)

1. Blakley BW. Clinical forum: a review of intratympanic therapy. Am J Otol 1997;18:520-6.
2. Wu IC, Minor LB. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease. Laryngoscope 2003;113:815-20.
3. Alzamil KS, Linthicum FH. Extraneous round window membranes and plugs: possible effect on intratympanic therapy. Ann Otol Rhinol Laryngol 2000;109:30-2.
4. Silverstein H, Todd Rowan P, Olds MJ, Rosenberg SI. Inner ear perfusion and role of round window patency. Am J Otol 1997;18:586-9.
5. Thomsen J, Charabi S, Tos M. Preliminary results of a new delivery system for gentamicin to the inner ear in patients with Meniere's disease. Eur Arch Otorhinolaryngol 2000; 257:362-5.
6. Hoffer ME, Kopke RD, Weisskopf P, Gottshall K, Allen K, Wester D, et al. Use of the round window microcatheter in the treatment of Menieres disease. Laryngoscope 2001;111: 2046-9.
7. Schoendorf J, Neugebauer P, Michel O. Continuous intratympanic infusion via a microcatheter in Meniere's disease. Otolaryngol Head Neck Surg 2001;124: 203-7.
8. Lefebvre PP, Staecker H. Steroid perfusion of the inner ear for sudden sensorineural hearing loss after failure of conventional therapy: a pilot study. Acta Otolaryngol 2002;122: 698-702.
9. Cayé-Thomasen P, Wagner N, Engmer C, Lauréll G, Bagger-Sjöbäck D, Thomsen J. An animal model for continuous drug administration to the inner ear. Audiol Med 2004;2:174-8.
10. Johnson A-C, Canlon B. Progressive hair cell loss induced by toluene exposure. Hear Res 1994;75:201-8.
11. Oei ML, Segenhout HM, Dijk F, Stokroos I, van der Want JJ, Albers FW. Functional and anatomic alterations in the gentamicin-damaged vestibular system in the guinea pig. Otol Neurotol 2004;25:57-64.
12. Hoffer ME, Allen K, Kopke RD, Weisskopf P, Gottshall K, Wester D. Transtympanic versus sustained release administration of gentamicin: kinetics, morphology, and function. Laryngoscope 2001;111:1343-57.
13. Hibi T, Suzuki T, Nakashima T. Perilymphatic concentration of gentamicin administered intratympanically in guinea pigs. Acta Otolaryngol 2001;121:336-41.
14. Plontke S, Wood AW, Salt AN. Analysis of gentamicin kinetics in fluids of the inner ear with round window administration. Otol Neurotol 2002;23:967-74.
15. Saijo S, Kimura RS. Distribution of HRP in the inner ear after injection into the middle ear cavity. Acta Otolaryngol (Stockh) 1984;97:593-610.
16. Salt AN, Ohyama K, Thalman R. Radial communication between the perilymphatic scalae of the cochlea. II: Estimation by bolus injection of tracer into the sealed cochlea. Hear Res 1991;51:37-43.
17. Laurell G, Teixeira M, Sterkers O, Bagger-Sjöbäck D, Eksborg S, Lidman O, et al. Local administration of antioxidants to the inner ear. Hear Res 2002;173: 198-209.
18. Imamura S, Adams JC. Distribution of gentamicin in the guinea pig inner ear after local or systemic application. J Assoc Res Otolaryngol 2003;4:176-95.
19. Imamura S, Adams JC. Changes in cytochemistry of sensory and nonsensory cells in gentamicin-treated cochleas. J Assoc Res Otolaryngol 2003;4:196-218.
20. Salt AN, Kellner C, Hale S. Contamination of perilymph sampled from the basal cochlear turn with cerebrospinal fluid. Hear Res 2003;182:24-33.
21. Walsted A. Unpredictable hearing loss after intratympanic gentamicin treatment for vertigo. A new theory. Acta Otolaryngol 2001;121:42-4.
22. Rask-Andersen H, Stahle J, Wilbrand H. Human cochlear aqueduct and its accessory canals. Ann Otol Rhinol Laryngol Suppl 1977;42:1-16.
23. Assimakopoulos D, Patrikakos G. Treatment of Meniere's disease by intratympanic gentamicin application. J Laryngol Otol 2003;117:10-6.